# FDA Inspection 807782 - Providence Health & Services - November 20, 2012

Source: https://www.keypedia.com/records/fda_inspections/providence-health-services/d617b03f-e8a9-4ade-ab04-6dfe8eae63f3
Source feed: FDA_Inspections

> FDA Inspection 807782 for Providence Health & Services on November 20, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 807782
- Company Name: Providence Health & Services
- Inspection Date: 2012-11-20
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1227754 - 2024-01-23](https://www.keypedia.com/records/fda_inspections/providence-health-services/dd107e1a-15cc-412b-9f89-40ab90d017ba)
- [FDA Inspection 1081587 - 2019-02-05](https://www.keypedia.com/records/fda_inspections/providence-health-services/d86849d2-0f9c-47ec-9bb8-737edfee4409)
- [FDA Inspection 1001441 - 2017-02-21](https://www.keypedia.com/records/fda_inspections/providence-health-services/bea28800-94f0-418d-a41f-12187eaf2de0)
- [FDA Inspection 899263 - 2014-10-08](https://www.keypedia.com/records/fda_inspections/providence-health-services/ac4a9e4f-8450-426b-8c26-fb752105456f)
- [FDA Inspection 701893 - 2010-12-09](https://www.keypedia.com/records/fda_inspections/providence-health-services/04d8a0d2-2ab2-4b05-bb08-d2bd4273264c)

Company: https://www.keypedia.com/companies/providence-health-services/3bef387c-b8b8-4407-8df1-8af8e8c4f229

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d